We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+16.88%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.03B
AUM Growth
-$287M
Cap. Flow
-$398M
Cap. Flow %
-38.68%
Top 10 Hldgs %
14.04%
Holding
1,478
New
335
Increased
269
Reduced
346
Closed
503

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$12.3M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$10.9M
3
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10.4M
4
TSLA icon
Tesla
TSLA
+$9.96M
5
NVDA icon
NVIDIA
NVDA
+$8.73M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$10.4M
2
AVGO icon
Broadcom
AVGO
+$9.33M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.68M
4
DESP
Despegar.com
DESP
+$7.15M
5
ORCL icon
Oracle
ORCL
+$6.74M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Consumer Discretionary 12.74%
3 Healthcare 12.34%
4 Communication Services 10.34%
5 Industrials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
976
CALL
Apple
AAPL
$4.57T
– –
-1,500
Closed -$333K
AAPL icon
977
PUT
Apple
AAPL
$4.57T
– –
-1,800
Closed -$400K
ABAT icon
978
American Battery Technology Co
ABAT
$356M
– –
-14,279
Closed -$14.7K
ABBV icon
979
AbbVie
ABBV
$435B
– –
-8,282
Closed -$1.74M
ABCB icon
980
Ameris Bancorp
ABCB
$5.89B
– –
-4,942
Closed -$285K
ABT icon
981
Abbott
ABT
$187B
– –
-6,785
Closed -$900K
ACET icon
982
Adicet Bio
ACET
$74.7M
– –
-2,140
Closed -$25.9K
ACRS icon
983
Aclaris Therapeutics
ACRS
$869M
– –
-11,791
Closed -$18K
ACRV icon
984
Acrivon Therapeutics
ACRV
$74M
– –
-13,067
Closed -$26.5K
ADM icon
985
Archer Daniels Midland
ADM
$36.9B
– –
-7,284
Closed -$350K
ADP icon
986
CALL
Automatic Data Processing
ADP
$108B
– –
-4,400
Closed -$1.34M
AGYS icon
987
Agilysys
AGYS
$3.06B
– –
-5,374
Closed -$390K
ALG icon
988
Alamo Group
ALG
$2.05B
– –
-1,431
Closed -$255K
ALGM icon
989
Allegro MicroSystems
ALGM
$8.16B
– –
-22,160
Closed -$557K
ALGN icon
990
Align Technology
ALGN
$12.3B
– –
-1,869
Closed -$297K
ALIT icon
991
Alight
ALIT
$407M
– –
-3,404
Closed -$404K
ALK icon
992
Alaska Air
ALK
$5.58B
– –
-17,860
Closed -$879K
ALNY icon
993
Alnylam Pharmaceuticals
ALNY
$29.3B
– –
-5,408
Closed -$1.46M
AMCR icon
994
Amcor
AMCR
$22.1B
– –
-2,730
Closed -$132K
AMED
995
CALL
DELISTED
Amedisys
AMED
– –
-8,300
Closed -$769K
AMKR icon
996
CALL
Amkor Technology
AMKR
$13.7B
– –
-43,400
Closed -$784K
AMT icon
997
American Tower
AMT
$80.4B
– –
-4,251
Closed -$925K
ANAB icon
998
AnaptysBio
ANAB
$1.68B
– –
-32,023
Closed -$595K
ANDE icon
999
Andersons Inc
ANDE
$2.22B
– –
-6,740
Closed -$289K
ANET icon
1000
PUT
Arista Networks
ANET
$238B
– –
-3,600
Closed -$279K
38 39
40
41 42

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Prelude Capital Management held 1,478 positions worth $1.03B, down 22% from $1.32B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management withdrew a net $398M in Q2 2025, closing 503 positions and reducing 346 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Alphabet (Google) Class C worth $11.7M.

  • Prelude Capital Management's largest Q2 2025 buy was Alphabet (Google) Class C: 65,723 shares worth $11.7M.
  • Prelude Capital Management added most to Meta Platforms (Facebook) in Q2 2025, an estimated $12.3M increase.
  • Prelude Capital Management's biggest Q2 2025 reduction was Broadcom, cutting an estimated $9.33M.
  • Prelude Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $10.4M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.03B portfolio in Q2 2025.
  • Prelude Capital Management opened 335 new positions and closed 503 in Q2 2025.
  • Prelude Capital Management's portfolio value fell 22% quarter-over-quarter to $1.03B.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.